Hong Kong was a big moment for Injective.
One thing I found interesting was the discussion around tokenized funds. Are they really creating a new market, or just bringing traditional finance onto the blockchain?
Injective joined the conversation with some of the biggest names in finance, including BlackRock, Fidelity International and Franklin Templeton.
Later, at the Investor Soiree, they also discussed how traditional ETFs and onchain markets can work together and what the future might look like.
And then came another big step.
Just hours after the discussion, Canary’s $INJC ETF officially started trading on Nasdaq.
I think this is an important step for Injective. It shows that the gap between traditional finance and blockchain is slowly getting smaller.
Still a lot to come for $INJ.
Big institutions are starting to take tokenized finance more seriously, and Injective is becoming part of that conversation.
At the Hong Kong Digital Asset Summit, Injective shared the stage with leading names like BlackRock, Fidelity International and Franklin Templeton to discuss the future of tokenized funds.
The discussion was about more than just putting traditional assets on a blockchain. It focused on some important questions:
How will these funds reach investors? Who will control distribution? And what infrastructure will support onchain settlement?
Injective also hosted an Investor Soirée at the Grand Hyatt, where Andrew Kang and Tom Digby from Invesco discussed how traditional ETFs and onchain markets can work closer together.
Another big moment came with the launch of $INJC, the Canary Staked INJ ETF, on Nasdaq.
This gives investors a new way to get exposure to $INJ through a familiar brokerage structure, while the fund also aims to earn staking rewards.
For me, the bigger story is how traditional finance and blockchain technology are gradually coming together.
And Injective is working to be part of that future.
What happens when traditional finance meets Injective?
$INJ is now getting more attention from traditional investors through Canary’s $INJC ETF, listed on Nasdaq.
The interesting part is that investors can gain exposure to INJ through a familiar brokerage account instead of managing crypto wallets or private keys.
And there’s more.
$INJC also includes a staking component, giving the fund an opportunity to earn staking rewards through Injective’s network.
This is another important step for Injective. It makes the ecosystem more accessible to traditional financial markets and creates a new way for investors to participate in its growth.
Crypto and traditional finance are getting closer, and Injective is becoming part of that connection.
Investing involves risk. INJC is not a direct investment in INJ. Staking rewards are not guaranteed.